These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2997173)

  • 1. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells.
    Morgan K; Lewis MD; Spurlock G; Collins PA; Foord SM; Southgate K; Scanlon MF; Mir MA
    J Biol Chem; 1985 Nov; 260(25):13595-600. PubMed ID: 2997173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An active sodium transport inhibitor released from spontaneously hypertensive and normotensive rat fetal hypothalamic cells in culture.
    Kendall JM; Thomas SE; Spurlock G; Mir MA
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):83S-87S. PubMed ID: 2843202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of an active sodium transport inhibitor (ASTI) from rat hypothalamic cells in culture.
    Morgan K; Foord SM; Spurlock G; Charalambous BM; Dieguez C; Scanlon MF; Mir MA
    Endocrinology; 1984 Oct; 115(4):1642-4. PubMed ID: 6148236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium transport inhibitor from bovine hypothalamus.
    Haupert GT; Sancho JM
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4658-60. PubMed ID: 228304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraction and characterization of a cytochemically assayable Na+/K+-ATPase inhibitor/glucose-6-phosphate dehydrogenase stimulator in the hypothalamus and plasma of man and the rat.
    Millett JA; Holland SM; Alaghband-Zadeh J; de Wardener HE
    J Endocrinol; 1987 Feb; 112(2):299-303. PubMed ID: 3029264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ; Baecker A; Weiler E; Liddiard C
    Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.
    Akagawa K; Hara N; Tsukada Y
    J Neurochem; 1984 Mar; 42(3):775-80. PubMed ID: 6319608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium retention and increased vascular reactivity caused by a hypothalamic sodium transport inhibitor.
    Mir MA; Morgan K; Chappell S; Lewis M; Spurlock G; Collins P; Collins P; Lewis M; Scanlon M
    Clin Sci (Lond); 1988 Aug; 75(2):197-202. PubMed ID: 3409635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus.
    Cantiello HF; Chen E; Ray S; Haupert GT
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F574-80. PubMed ID: 2845805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brain Na+, K+-ATPase inhibitor (endobain E) enhances norepinephrine release in rat hypothalamus.
    Vatta M; Peña C; Fernández B; Rodríguez de Lores Arnaiz G
    Neuroscience; 1999 May; 90(2):573-9. PubMed ID: 10215160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems and pitfalls in the isolation of an endogenous Na+, K+-ATPase inhibitor.
    Mir MA; Morgan K; Lewis M; Spurlock G; Chappell S; Lewis M; Scanlon M
    Hypertension; 1987 Nov; 10(5 Pt 2):I57-60. PubMed ID: 2824367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification from human plasma of endogenous sodium transport inhibitor(s).
    Cloix JF; Dagher G; Crabos M; Pernollet MG; Meyer P
    Experientia; 1984 Dec; 40(12):1380-2. PubMed ID: 6096160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na,K-ATPase inhibitor from guinea pig brain is not ouabain-like.
    Kracke GR
    J Lab Clin Med; 1983 Jan; 101(1):105-13. PubMed ID: 6294201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the hypothalamus may be a source of a circulating Na+-K+-ATPase inhibitor.
    Alaghband-Zadeh J; Fenton S; Hancock K; Millett J; de Wardener HE
    J Endocrinol; 1983 Aug; 98(2):221-6. PubMed ID: 6308123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential properties between an endogenous brain Na+, K(+)-ATPase inhibitor and ouabain.
    Peña C; Rodríguez de Lores Arnaiz G
    Neurochem Res; 1997 Apr; 22(4):379-83. PubMed ID: 9130247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.